BioSpace News Archive

Stryker’s Trauma & Extremities division has launched its Citrelock™ Tendon Fixation Device System.

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has received clearance from the US FDA regarding the IND application to initiate clinical trials of SACT-1, an orally administered repurposed small molecule drug for the treatment of neuroblastoma.

MAIA Biotechnology, Inc. announced today the formation of its Scientific Advisory Board (SAB)

Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the second quarter of fiscal 2022, the period ended July 31, 2021

PDS Biotechnology Corporation announced that the compensation committee of the board of directors of the Company approved, on September 13, 2021, an equity award to Gregory Reid, the Company’s new VP of Program Development, as a material inducement to Mr. Reid entering into employment with PDS Biotech.

Resonant Inc. will host a “5G Insights in Japan” webinar on Thursday, September 30, 2021 (Wednesday, September 29, 2021, in the US).

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab

The Rare Disease Cures Accelerator-Data and Analytics Platform initiative officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation.

NextGen Healthcare to Participate at the Cantor Virtual Global Healthcare 2021 Conference

Paragonix Technologies announces the launch of a new collaboration with the University of Nebraska Medical Center on a novel method to advance heart transplantation utilizing DCD (donation after circulatory death) donors.